The Oncology Institute, Inc.

NasdaqCM:TOI 주식 보고서

시가총액: US$33.4m

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Oncology Institute 관리

관리 기준 확인 2/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Dan Virnich

최고 경영자

US$808.1k

총 보상

CEO 급여 비율56.3%
CEO 임기less than a year
CEO 소유권0.8%
경영진 평균 재임 기간1.6yrs
이사회 평균 재임 기간2.6yrs

최근 관리 업데이트

Recent updates

The Oncology Institute, Inc. (NASDAQ:TOI) Stock's 29% Dive Might Signal An Opportunity But It Requires Some Scrutiny

May 05
The Oncology Institute, Inc. (NASDAQ:TOI) Stock's 29% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Not Many Are Piling Into The Oncology Institute, Inc. (NASDAQ:TOI) Stock Yet As It Plummets 28%

Mar 21
Not Many Are Piling Into The Oncology Institute, Inc. (NASDAQ:TOI) Stock Yet As It Plummets 28%

Is Oncology Institute (NASDAQ:TOI) A Risky Investment?

Mar 05
Is Oncology Institute (NASDAQ:TOI) A Risky Investment?

The Oncology Institute, Inc. (NASDAQ:TOI) Stock Rockets 49% But Many Are Still Ignoring The Company

Nov 10
The Oncology Institute, Inc. (NASDAQ:TOI) Stock Rockets 49% But Many Are Still Ignoring The Company

The Oncology Institute swings to Q2 GAAP loss per share from year-ago profit

Aug 09

Shareholders Shouldn’t Be Too Comfortable With Oncology Institute's (NASDAQ:TOI) Strong Earnings

May 18
Shareholders Shouldn’t Be Too Comfortable With Oncology Institute's (NASDAQ:TOI) Strong Earnings

Companies Like Oncology Institute (NASDAQ:TOI) Are In A Position To Invest In Growth

Mar 16
Companies Like Oncology Institute (NASDAQ:TOI) Are In A Position To Invest In Growth

The Oncology Institute: Capitalizing On Clinical Research Contracts

Dec 22

CEO 보상 분석

Dan Virnich 의 보수는 Oncology Institute 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Mar 31 2024n/an/a

-US$60m

Dec 31 2023US$808kUS$455k

-US$68m

Sep 30 2023n/an/a

-US$61m

Jun 30 2023n/an/a

-US$50m

Mar 31 2023n/an/a

-US$40m

Dec 31 2022US$3mUS$446k

US$68k

Sep 30 2022n/an/a

-US$1m

Jun 30 2022n/an/a

-US$2m

Mar 31 2022n/an/a

US$6m

Dec 31 2021US$8mUS$263k

-US$11m

Sep 30 2021n/an/a

-US$6m

Jun 30 2021n/an/a

-US$3m

Mar 31 2021n/an/a

-US$5m

Dec 31 2020US$419kUS$214k

-US$14m

보상 대 시장: Dan 의 총 보상 ($USD 808.13K )은 US 시장에서 비슷한 규모의 회사의 평균 수준입니다( $USD 683.56K ).

보상과 수익: Dan 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.


CEO

Dan Virnich (45 yo)

less than a year

테뉴어

US$808,129

보상

Dr. Daniel Virnich, also known as Dan, M.D., MBA, FACHE, is Chief Executive Officer of The Oncology Institute Inc. since June 2023 and serves as its Executive Director since June 13, 2024. He served as Pre...


리더십 팀

이름위치테뉴어보상소유권
Richard Barasch
Chairman of the Board4.6yrsUS$162.40k0.35%
$ 115.5k
Daniel Virnich
CEO & Executive Directorless than a yearUS$808.13k0.78%
$ 260.9k
Mihir Shah
Chief Financial Officer2.2yrsUS$801.74k0.22%
$ 72.6k
Yale Podnos
Chief Medical Officer2.6yrsUS$591.28k0.057%
$ 19.0k
Jeremy Castle
Chief Operations Officerless than a year데이터 없음데이터 없음
Mark Hueppelsheuser
General Counsel9.4yrs데이터 없음데이터 없음
Laura Szitar
Chief People Officerno data데이터 없음데이터 없음
Jordan McInerney
Chief Development Officerless than a year데이터 없음데이터 없음

1.6yrs

평균 재임 기간

46yo

평균 연령

경험이 풍부한 관리: TOI 의 관리팀은 경험 (평균 재직 기간 1.6 년)으로 간주되지 않으므로 새로운 팀을 추천합니다.


이사회 구성원

이름위치테뉴어보상소유권
Richard Barasch
Chairman of the Board4.6yrsUS$162.40k0.35%
$ 115.5k
Daniel Virnich
CEO & Executive Directorno dataUS$808.13k0.78%
$ 260.9k
Mark Pacala
Independent Director1.8yrsUS$160.32k0.12%
$ 39.7k
Bradford Hively
Vice Chairman2.6yrsUS$1.34m0.56%
$ 187.7k
Anne McGeorge
Independent Director2.6yrsUS$188.81k0.096%
$ 32.0k
Gabe Ling
Director1.8yrsUS$143.70k0.039%
$ 13.0k
Maeve O'Meara
Independent Director2.6yrsUS$171.89k0.079%
$ 26.5k
Mohit Kaushal
Independent Director4.3yrsUS$180.22k0.12%
$ 39.8k
Karen Johnson
Independent Director2.6yrsUS$177.53k0.085%
$ 28.4k

2.6yrs

평균 재임 기간

62.5yo

평균 연령

경험이 풍부한 이사회: TOI 의 이사회경험(평균 재직 기간 2.6 년)으로 간주되지 않으므로 새 이사회가 필요합니다.